Cardinal Health (NYSE: CAH), Dublin, OH, reported sales for the fiscal 2015 second quarter ended Dec. 31 of $25.5 billion, a 15 percent increase compared to the same period a year ago. Profit increased 4 percent to $289 million.

Pharmaceutical segment sales increased 16 percent year-over-year to $22.6 billion due to growth in the base of existing customers as well as the impact of new customers. Segment profit increased 12 percent to $542 million, driven by strong performance under generic programs, which includes the net benefit of Red Oak Sourcing, as well as continued growth from existing customers and growth from new customers.

For the first six months, Cardinal Health reported sales of $49.6 billion, a 6 percent increase compared to the same period a year ago. Profit decreased 10 percent to $555 million.